Back
Biomarin Pharmaceutical Stock Price Chart
Sponsored
BMRN
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
BMRN
Biomarin Pharmaceutical
Last Price:
64.27
Seasonality Move:
12.47%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Biomarin Pharmaceutical Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.96 | Sell |
20-day SMA: | 65.96 | Sell |
50-day SMA: | 68.96 | Sell |
200-day SMA: | 81.18 | Sell |
8-day EMA: | 63.79 | Sell |
20-day EMA: | 65.7 | Sell |
50-day EMA: | 69.97 | Sell |
200-day EMA: | 79.54 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.1 | Sell |
Relative Strength Index (14 RSI): | 33.54 | Sell |
Chaikin Money Flow: | 933432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.12 - 69.52) | Sell |
Bollinger Bands (100): | (68.19 - 87.29) | Sell |
Biomarin Pharmaceutical Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 63.45 while BMRN 8-day simple moving average is 63.96, which is a Sell signal.
- The stock price of BMRN is 63.45 while Biomarin Pharmaceutical 20-day SMA is 65.96, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 68.96 while BMRN share price is 63.45, making it a Sell technically.
- BMRN stock price is 63.45 and Biomarin Pharmaceutical 200-day simple moving average is 81.18, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Buy
The current Biomarin Pharmaceutical [BMRN] share price is $63.45. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
12.09B
Price in USD:
63.45
Share Volume:
1.27M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
61.15
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 63.45 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 63.45 while BMRN 8-day exponential moving average is 63.79, which is a Sell signal.
- The stock price of BMRN is 63.45 while Biomarin Pharmaceutical 20-day EMA is 65.70, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 69.97 while BMRN share price is 63.45, making it a Sell technically.
- BMRN stock price is 63.45 and Biomarin Pharmaceutical 200-day simple moving average is 79.54, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -2.1, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 33.54, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (64.12 - 69.52), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (68.19 - 87.29), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.